Clinical trial
Combination Therapy of Betaseron-Prograf in Multiple Sclerosis
NCT00298662 · Clinique de sclérose en plaques et neuromusculaire de l'Outaouais, Other · Unknown status
Key facts
| NCT number | NCT00298662 |
|---|---|
| Title | Combination Therapy of Betaseron-Prograf in Multiple Sclerosis |
| Official title | A Pilot Safety and Tolerability Open-Label Study of Interferon Beta-1b in Combination With Tacrolimus in Patients Suffering From Multiple Sclerosis Who Have Failed Treatment With Approved Disease Modifying Agents |
| Lead sponsor | Clinique de sclérose en plaques et neuromusculaire de l'Outaouais, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Interferon beta-1b and Tacrolimus |
| Enrollment | 30 |
| Start date | Feb 1, 2003 |
| Completion | Sep 1, 2006 |
| First posted | Mar 3, 2006 |
| Last update posted | Mar 3, 2006 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: